Edition:
United Kingdom

People: Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

98.04USD
24 May 2019
Change (% chg)

$0.40 (+0.41%)
Prev Close
$97.64
Open
$97.65
Day's High
$98.27
Day's Low
$96.69
Volume
154,300
Avg. Vol
301,844
52-wk High
$116.43
52-wk Low
$78.97

Rusckowski, Stephen 

Mr. Stephen H. Rusckowsk is Chairman of the Board, President, Chief Executive Officer of the Company. Mr. Rusckowski has been President and Chief Executive Officer of Quest Diagnostics since May 2012 and Chairman of the Board since January 2017. From November 2006 to May 2012, Mr. Rusckowski was the Chief Executive Officer of Philips Healthcare, the largest unit of Royal Philips Electronics, and a member of the Board of Management of Royal Philips Electronics and its Executive Committee. He joined Philips when it acquired Agilent’s Healthcare Solutions Group in 2001, and was the CEO of Philips Imaging Systems business group before assuming his role as CEO of Philips Healthcare. Mr. Rusckowski served as the Chairman of the American Clinical Laboratory Association from March 2014 to March 2017. He is a director of Xerox Corporation and was a director of Covidien plc from December 2013 to January 2015.

Basic Compensation

Total Annual Compensation, USD 2,543,420
Restricted Stock Award, USD 4,500,070
Long-Term Incentive Plans, USD --
All Other, USD 3,304,530
Fiscal Year Total, USD 10,348,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Stephen Rusckowski

10,348,000

Mark Guinan

3,460,400

James Davis

3,270,240

Gabrielle Wolfson

--

Michael Prevoznik

2,090,390

Jon Cohen

2,491,990
As Of  31 Dec 2017